HBS: Therapy Related Malignant Hematology & Oncology Emergencies, 11/22/17

San Francisco, CA US
November 22, 2017

Target Audience

All hospital-based specialties.

Learning Objectives

After participation in this CME activity, the learner will be able to:

  1. Discuss the side-effect profile of traditional chemotherapy.
  2. Recognize the side-effects of novel B-cell lymphoma therapies.
  3. Describe cultural implications to treating lung cancers and modern side-effects of lung cancer treatment.
  4. Anticipate the emergencies related to the emerging field of immunotherapy.

Additional Information

San Francisco Medical Center
Conference room: 
2425 Geary Blvd. Mezz 1
Course summary
Available credit: 
  • 0.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
Course expires: 
Event starts: 
11/22/2017 - 12:30pm PST
Event ends: 
11/22/2017 - 1:30pm PST
San Francisco Medical Center
2425 Geary Blvd
Mezz 2 and 3
San Francisco, CA 94115
United States

Planner: Jeanna Goo, MD MPH, Department of Hospital Medicine, HBS CME Coordinator, KPSF

Speaker: Raymond Liu, MD

Disclosure Statement: The faculty and planners for this activity, as well as the CME staff, do not have any relevant financial relationships with commercial interests or affiliations to disclose.

Accreditation Statement: The Kaiser San Francisco (San Francisco, CA 94115) is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.

Available Credit

  • 0.00 AAFP
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Please login or register to take this course.